Kymera Therapeutics, Inc. (KYMR) Analyst Forecast

$44.79

$0.26 (0.58%)
Last update: 01:00 PM EST
Day's range
$44.26
Day's range
$45.15

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
06/27/2025 Oppenheimer Jeff Jones $53.00 $44.12   20.13%
06/26/2025 BTIG Jeet Mukherjee $59.00 $46.47   26.96%
06/25/2025 Jefferies Kelly Shi $64.00 $46.21   38.5%
06/03/2025 Guggenheim Michael Schmidt $60.00 $43.58   37.68%
12/05/2024 BMO Capital Etzer Darout $55.00 $44.08   24.77%
12/02/2024 Wells Fargo Derek Archila $57.00 $48.54   17.44%
09/27/2024 Oppenheimer Jeff Jones $56.00 $49.47   13.2%
08/26/2024 Wolfe Research Andy Chen $65.00 $47.78   36.04%
08/08/2024 H.C. Wainwright Andrew Fein $60.00 $40.31   48.85%
06/17/2024 H.C. Wainwright Andrew Fein $46.00 $32.29   42.46%
05/23/2024 Piper Sandler Edward Tenthoff $56.00 $34.84   60.76%
05/03/2024 Oppenheimer Jeff Jones $52.00 $36.30   43.25%
12/06/2022 Morgan Stanley Michael Turits $45.20 $29.11   55.27%
12/05/2022 Credit Suisse Richard Law $32.00 $29.11   9.93%
05/19/2021 UBS Eliana Merle $80.00 $43.20   85.19%

Kymera Therapeutics, Inc. FAQ's

Kymera Therapeutics, Inc. has been rated by research analysts at Oppenheimer, BTIG, Jefferies, Guggenheim, H.C. Wainwright, BMO Capital in the past 90 days.